First drug for complete cancer cure successful in initial tests?

Cancer free after only a few weeks of treatment?

Unfortunately, cancer costs more and more people's lives. Physicians all over the world are looking for ways to prevent cancer, improve existing therapies, or, at best, bring about complete cure for the disease. Israeli scientists now claim that they have developed a cure for cancer that could be completed in a year and can cure the disease completely in just a few weeks.

The Experts of Accelerated Evolution Biotechnologies Ltd. They said they could offer a cure for cancer in the future, which can cure the disease in just a few weeks, reports The Jerusalem Post. The treatment should have no or minimal side effects and be available at substantially lower cost than most other treatments available on the market.

Have scientists really succeeded in achieving the decisive breakthrough in the treatment of cancer? (Image: science photo / fotolia.com)

Treatment only takes a few weeks

The new treatment for curing cancer is effective from the first day, lasts only a few weeks and has no or minimal side effects. The intended solution will be both generic and personal, the researchers explain to the newspaper.

When will multi-target toxin be available to humans?

While scientists may indeed have evidence that their medicine could be completed in just one year, it is likely that patients will have to wait up to a decade before treatment is actually available. First, it must be confirmed that the therapy is safe and effective. The drug is called MuTaTo (multi-target toxin). It works like an antibiotic against cancer, say the developers.

Why are many treatments of cancer unsuccessful?

In their research, the experts wanted to find out why other cancer medicines and treatments do not work or eventually cease to be effective. Then they set about finding a solution to these problems. Most anti-cancer medicines only target a specific target or cancer cell, the researchers explain. They fail because the target mutates. Cancer cells begin to divide and spread in order to avoid successful treatment. Thus, the original drug that has attacked this target, eventually useless and the therapy does not work anymore.

Drug attacks three targets simultaneously

MuTaTo is not affected by mutations because the treatment attacks three targets simultaneously. Not even cancer can mutate three receptors at the same time, say the scientists. The treatment could distinguish between healthy and non-healthy, diseased cells. This will reduce the unpleasant side effects that occur with most topical treatments like chemotherapy.

So far, there were only success in experiments with mice

So far, however, the researchers' claims are based only on experiments on mice. The next step would be proof in the lab that treatment on human cancer models works, explain the experts. If there is evidence that the drug is effective in such a laboratory trial, scientists would need to go through Phase I, II, and III clinical trials to determine if it is really safe and effective in humans. Unfortunately, it may take ten to fifteen years or more for all three phases of pre-licensing clinical trials to be completed.

MuTaTo will enable highly personalized treatment

Factors including the type of cancer, the type of treatment and the duration of treatment can all affect the duration of taking medication. MuTaTo will one day allow cancer patients a highly personalized treatment, biopsies could be sent for testing, so that doctors can determine the exact dose each patient needs to cure their disease, say the doctors.

Patients remain disease-free even after treatment

The treatment can only take a few weeks to cure at best. Patients remain disease-free after treatment is completed, the researchers say. But the experts had to admit that they are just beginning clinical trials that may take years to complete. Although the doctors' statements are quite exciting, there still seems to be a long way to go before the prospect of a cure for cancer exists. (As)